Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sagimet Biosciences Inc Series A (SGMT)

Sagimet Biosciences Inc Series A (SGMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sagimet Biosciences Inc Series A 155 BOVET RD. SUITE 303 SAN MATEO CA 94402 USA

www.sagimet.com Employees: 16 P: 650-561-8600

Sector:

Medical

Description:

Sagimet Biosciences Inc. is a clinical-stage biopharmaceutical company. It involved in developing novel therapeutics targeting dysfunctional metabolic pathways. Sagimet Biosciences Inc. is based in SAN MATEO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 173,352
Enterprise Value, $K 138,332
Shares Outstanding, K 32,585
Float, K 27,795
% Float 85.30%
Short Interest, K 3,804
Short Float 11.67%
Days to Cover 12.57
Short Volume Ratio 0.44
% of Insider Shareholders 14.70%
% of Institutional Shareholders 87.86%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -51,040 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -9,570 K
EBIT, $ -56,900 K
EBITDA, $ -57,290 K

Growth:

1-Year Return 111.11%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.29 on 03/11/26
Next Earnings Date 05/14/26
Earnings Per Share ttm -1.57
EPS Growth vs. Prev Qtr 27.50%
EPS Growth vs. Prev Year 42.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

SGMT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -40.85%
Return-on-Assets % -38.63%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.53
Book Value/Share 3.42
Interest Coverage -1.86
60-Month Beta 3.17
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.